What is the address of dr. Marleen Valckenborgh Anesthesie?

The registered office of dr. Marleen Valckenborgh Anesthesie is located at Beekboshoek 150 box A, 2550 Kontich.

Is dr. Marleen Valckenborgh Anesthesie still active?

Yes. According to the CBE (18 September 2026) dr. Marleen Valckenborgh Anesthesie is active, legal situation “Normale toestand”, started on 20 December 2019.

Is dr. Marleen Valckenborgh Anesthesie registered on Peppol?

Yes, dr. Marleen Valckenborgh Anesthesie is registered on the Peppol network with ID 0208:0739870369.

What is the enterprise number of dr. Marleen Valckenborgh Anesthesie?

The enterprise number of dr. Marleen Valckenborgh Anesthesie is BE0739870369.

When was dr. Marleen Valckenborgh Anesthesie founded?

dr. Marleen Valckenborgh Anesthesie was founded on 20 December 2019.

Who are the directors of dr. Marleen Valckenborgh Anesthesie?

According to the 2024 annual accounts, the directors of dr. Marleen Valckenborgh Anesthesie are: Marleen Valckenborgh.

Is dr. Marleen Valckenborgh Anesthesie a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 20 December 2019; 4 annual accounts filed, latest fiscal year 2024; 1 directors known from the annual account.

How much profit did dr. Marleen Valckenborgh Anesthesie make in 2024?

dr. Marleen Valckenborgh Anesthesie posted a profit after taxes of € 238,798 in financial year 2024.

What is the revenue of dr. Marleen Valckenborgh Anesthesie?

As a small company, dr. Marleen Valckenborgh Anesthesie is not required to publish revenue in its annual accounts. In financial year 2024, its added value was € 317,723.

dr. Marleen Valckenborgh Anesthesie (Private Limited)

Dossier dr. Marleen Valckenborgh Anesthesie, printed on 18 September 2026 from databakkes.be/en/0739870369/dr-marleen-valckenborgh-anesthesie. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2024

dr. Marleen Valckenborgh Anesthesie from Kontich, company number BE0739870369, closed financial year 2024 with a result of € 238,798 after tax. For that financial year dr. Marleen Valckenborgh Anesthesie recorded a gross margin of € 317,723 and equity of € 453,791. Compared with financial year 2023, the result moved from € 215,468 to € 238,798. Profitable, and profit is growing. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on September 30, 2025.

What it is worth Healthy

€ 453,791

▼ 44% vs 2023

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 238,798

▲ 11% vs 2023

Profit after tax over the fiscal year.

Cash in the bank

€ 24,845

▼ 82% vs 2023

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 600,000 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2024

Vehicles and equipment

€ 10,090

▲ 70% vs 2023

Book value of vehicles, furniture and equipment.

Debts at end 2024

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 4,965

▼ 43% vs 2023

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 20,324

▲ 63% vs 2023

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2021	2022	2023	2024	Change 2023 → 2024
Gross margin	€ 267,433 Gross margin 2021: € 267,433 First fiscal year in the series	€ 222,114 Gross margin 2022: € 222,114 ▼ 17% vs 2021 (€ 267,433) Unfavourable step	€ 287,466 Gross margin 2023: € 287,466 ▲ 29% vs 2022 (€ 222,114) Favourable step	€ 317,723 Gross margin 2024: € 317,723 ▲ 11% vs 2023 (€ 287,466) Favourable step	▲ 11%
Profit after taxes	€ 194,113 Profit after taxes 2021: € 194,113 First fiscal year in the series	€ 168,564 Profit after taxes 2022: € 168,564 ▼ 13% vs 2021 (€ 194,113) Unfavourable step	€ 215,468 Profit after taxes 2023: € 215,468 ▲ 28% vs 2022 (€ 168,564) Favourable step	€ 238,798 Profit after taxes 2024: € 238,798 ▲ 11% vs 2023 (€ 215,468) Favourable step	▲ 11%
Equity	€ 430,961 Equity 2021: € 430,961 First fiscal year in the series	€ 599,525 Equity 2022: € 599,525 ▲ 39% vs 2021 (€ 430,961) Favourable step	€ 814,993 Equity 2023: € 814,993 ▲ 36% vs 2022 (€ 599,525) Favourable step	€ 453,791 Equity 2024: € 453,791 ▼ 44% vs 2023 (€ 814,993) Unfavourable step	▼ 44%
Total debts	€ 96,859 Total debts 2021: € 96,859 First fiscal year in the series	€ 17,891 Total debts 2022: € 17,891 ▼ 82% vs 2021 (€ 96,859) Favourable step	€ 21,404 Total debts 2023: € 21,404 ▲ 20% vs 2022 (€ 17,891) Unfavourable step	€ 25,417 Total debts 2024: € 25,417 ▲ 19% vs 2023 (€ 21,404) Unfavourable step	▲ 19%
Cash	€ 63,088 Cash 2021: € 63,088 First fiscal year in the series	€ 101,890 Cash 2022: € 101,890 ▲ 62% vs 2021 (€ 63,088) Favourable step	€ 140,304 Cash 2023: € 140,304 ▲ 38% vs 2022 (€ 101,890) Favourable step	€ 24,845 Cash 2024: € 24,845 ▼ 82% vs 2023 (€ 140,304) Unfavourable step	▼ 82%
Retained profit	€ 428,461 Retained profit 2021: € 428,461 First fiscal year in the series	€ 597,025 Retained profit 2022: € 597,025 ▲ 39% vs 2021 (€ 428,461) Favourable step	€ 812,493 Retained profit 2023: € 812,493 ▲ 36% vs 2022 (€ 597,025) Favourable step	€ 451,291 Retained profit 2024: € 451,291 ▼ 44% vs 2023 (€ 812,493) Unfavourable step	▼ 44%
Dividend	€ 0 Dividend 2021: € 0 First fiscal year in the series	€ 0 Dividend 2022: € 0 Unchanged (€ 0) Unchanged	€ 0 Dividend 2023: € 0 Unchanged (€ 0) Unchanged	€ 600,000 Dividend 2024: € 600,000 Unchanged (€ 0) Unchanged
Bank debt	€ 0 Bank debt 2021: € 0 First fiscal year in the series	€ 0 Bank debt 2022: € 0 Unchanged (€ 0) Unchanged	€ 89 Bank debt 2023: € 89 Unchanged (€ 0) Unfavourable step	€ 0 Bank debt 2024: € 0 ▼ 100% vs 2023 (€ 89) Favourable step	▼ 100%
Balance sheet total	€ 527,820 Balance sheet total 2021: € 527,820 First fiscal year in the series	€ 617,416 Balance sheet total 2022: € 617,416 ▲ 17% vs 2021 (€ 527,820) Unchanged	€ 836,397 Balance sheet total 2023: € 836,397 ▲ 35% vs 2022 (€ 617,416) Unchanged	€ 479,207 Balance sheet total 2024: € 479,207 ▼ 43% vs 2023 (€ 836,397) Unchanged	▼ 43%

Key figures of dr. Marleen Valckenborgh Anesthesie, fiscal years 2021 to 2024, from the annual accounts filed with the National Bank of Belgium.The annual account for fiscal year 2025 has not been filed yet; it was expected before 31 July 2026.

What happened to dr. Marleen Valckenborgh Anesthesie?

What happened at dr. Marleen Valckenborgh Anesthesie in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Sep 30, 2025 New annual accounts for financial year 2024: profit of € 238,798 (▲ 11% vs 2023). filed late Source: NBB ↗
Dec 20, 2019 New establishment in Kontich. KBO
Dec 20, 2019 Start of the company according to the CBE. KBO

In short

From € 194,113 profit in 2021 to € 238,798 profit in 2024.

Paid € 261,848 in corporate taxes since 2021.

Best year ever: 2024, with € 238,798 profit.

Paid out € 600,000 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at dr. Marleen Valckenborgh Anesthesie? We notify you, reason included.

Follow dr. Marleen Valckenborgh Anesthesie

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Marleen Valckenborgh

dr. Marleen Valckenborgh Anesthesie

Behind dr. Marleen Valckenborgh Anesthesie is Marleen Valckenborgh.

See the full network in the app

Directors

According to the 2024 annual accounts

Marleen Valckenborgh

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Beekboshoek 150 box A

2550 Kontich

2.300.583.840

Beekboshoek 150A

2550 Kontich

Active since 20 December 2019

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0739.870.369
VAT number: BE 0739.870.369
Registered office: Beekboshoek 150 bus A, 2550 Kontich
Names & denominations: dr. Marleen Valckenborgh Anesthesie
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 20 December 2019
Peppol: Active · Active since 30 Nov 2025
Contact: [email protected] 0477/931221

View on CBE Public ↗ Annual accounts (NBB) ↗